Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Iscience|February 6, 2023
Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal modelTakuya Tada, Belinda M Dcosta, Hao Zhou, et al.Journal for Immunotherapy of Cancer|April 24, 2024
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer modelsTakuya Tada, Thomas D Norton, Rebecca Leibowitz, et al.Biorxiv : the Preprint Server for Biology|January 19, 2023
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor DecoyTakuya Tada, Belinda M Dcosta, Hao Zhou, et al.Frontiers in Microbiology|January 2, 2014
Transgenic expression of the human LEDGF/p75 gene relieves the species barrier against HIV-1 infection in mouse cellsTakuya Tada, Motohiko Kadoki, Yang Liu, et al.JCI Insight|April 10, 2023
Single-epitope T cell-based vaccine protects against SARS-CoV-2 infection in a preclinical animal modelTakuya Tada, Ju-Yi Peng, Belinda M Dcosta, et al.Journal of Orthopaedic Case Reports|June 25, 2021
A dorsal approach for the distal-to-proximal internal fixation of oblique scaphoid fracturesTakuya Tada, Kenji Onuma, Koji Sukegawa, et al.Elife|August 12, 2020
MARCH8 inhibits viral infection by two different mechanismsYanzhao Zhang, Takuya Tada, Seiya Ozono, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2019
Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized MiceThomas D Norton, Anjie Zhen, Takuya Tada, et al.Science Advances|December 9, 2022
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactionsShaun M Christie, Takuya Tada, Yandong Yin, et al.Biorxiv : the Preprint Server for Biology|February 23, 2021
Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodiesTakuya Tada, Belinda M Dcosta, Hao Zhou, et al.Pageof 6